EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Longitudinal Assessment of QT Apex in Tumor-Bearing Dogs Receiving Doxorubicin Monotherapy

Keita Kitagawa iD, Jacob Ryave, Robert A Sanders iD, Ji-Hyun Lee, Zhongyue Zhang, Paulo Vilar Saavedra iD

Journal of Veterinary Internal Medicine · 2025

DOI: 10.1111/jvim.70169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2025. Verfasst von Keita Kitagawa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Doxorubicin, Dog Diseases, Antibiotics, Antineoplastic, Neoplasms. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The cardiac morphologic and functional derangements induced by doxorubicin (DOX) are referred to as DOX-induced cardiotoxicity (DOX-IC). Prolongation of the QT apex (QTa) has been identified as a potential marker for the early detection of DOX-IC in humans.

Objectives

Describe changes in QTa that occur in dogs with cancer undergoing DOX monotherapy. Animals Forty-five client-owned dogs.

Methods

Descriptive analysis of data routinely recorded as part of case management of dogs with cancer. Dogs included in the study had a confirmed malignant neoplasm, received DOX as a monotherapy, and had at least 4 ECGs > 30 s. All ECGs included in the study were recorded before DOX administration. Five heartbeats with a stable signal and minimal artifact were randomly selected from each dog, and the QTa was blindly evaluated in lead II, lead III, or both. Subsequently, a linear mixed model was used to quantify the effect of a cumulative dose of DOX on the QTa interval, adjusting for the effect of the other clinical variables.

Results

Forty-five dogs met the inclusion criteria. Among them, 39/45 received five DOX treatments and 26/45 received six DOX treatments. For ECG analysis, 234 ECGs were evaluated for changes in the QTa. The average cumulative dose of DOX was 154.1 mg/m2. There was no significant impact of the DOX treatments on the change in QTa (p = 0.8).

Conclusions

Administration of DOX up to a cumulative dose of 154.1 mg/m2 does not result in QTa prolongation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinDog DiseasesAntibiotics, AntineoplasticNeoplasmsAnimalsDogsElectrocardiographyFemaleMaleLongitudinal StudiesCardiotoxicity

Stichwörter der Autor:innen

QTacardiotoxicitychemotherapydoxorubicinelectrocardiogram

Substanzen

DoxorubicinAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA.
  • Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA.
  • Department of Biostatistics, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Division of Quantitative Sciences, University of Florida Health Cancer Center, University of Florida, Gainesville, Florida, USA.

ORCID-Profile: Keita Kitagawa, Robert A Sanders, Paulo Vilar Saavedra

Zitieren

APA

Kitagawa, K., Ryave, J., Sanders, R. A., Lee, J. H., Zhang, Z., & Vilar Saavedra, P. (2025). Longitudinal Assessment of QT Apex in Tumor-Bearing Dogs Receiving Doxorubicin Monotherapy. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.70169

Vancouver

Kitagawa K, Ryave J, Sanders RA, Lee JH, Zhang Z, Vilar Saavedra P. Longitudinal Assessment of QT Apex in Tumor-Bearing Dogs Receiving Doxorubicin Monotherapy. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.70169

BibTeX
@article{Kitagawa2025,
  author = {Kitagawa, Keita and Ryave, Jacob and Sanders, Robert A and Lee, Ji-Hyun and Zhang, Zhongyue and Vilar Saavedra, Paulo},
  title = {Longitudinal Assessment of QT Apex in Tumor-Bearing Dogs Receiving Doxorubicin Monotherapy},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2025},
  doi = {10.1111/jvim.70169}
}
Kostenlos starten →